Cartesian Therapeutics, Inc.
RNAC
$8.84
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -318.89% | -296.17% | -68.30% | 80.40% | 84.21% |
| Total Depreciation and Amortization | 3.62% | 13.84% | 157.08% | 202.77% | 199.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 379.94% | 553.71% | 5.27% | -107.65% | -111.65% |
| Change in Net Operating Assets | -79.92% | 85.96% | -39.23% | 92.67% | 156.77% |
| Cash from Operations | -125.48% | -136.41% | -212.33% | -58.24% | 46.01% |
| Capital Expenditure | 80.30% | 53.94% | 40.02% | 32.95% | -369.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 79.62% | 52.19% | 37.61% | -181.12% | -337.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.05% | -87.42% | -99.75% | -99.12% | 3,785.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.25% | 97.95% | -12,593.94% | -35.22% | -34.53% |
| Cash from Financing | -43.80% | -86.67% | -104.78% | -103.97% | 261.59% |
| Foreign Exchange rate Adjustments | -321.43% | -62.50% | 314.29% | 90.00% | 180.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.38% | -179.85% | -164.27% | -154.15% | 380.23% |